NCT02975440 - Drug-drug Interaction Study Between Orally Administered Rifampicin and Vilaprisan | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 10, 2016

Primary Completion Date

January 27, 2017

Study Completion Date

April 11, 2017

Conditions

Endometriosis

Interventions

DRUG

Rifampicin

11 single oral doses of 600 mg Rifampicin resulting in a total dose of 6600 mg Rifampicin.

DRUG

Midazolam

2 single oral doses of 1 mg Midazolam resulting in a total dose of 2 mg Midazolam

DRUG

BAY1002670_Vilaprisan

2 single oral doses of 4 mg Vilaprisan resulting in a total dose of 8 mg Vilaprisan

Trial Locations (1)

Berlin